<DOC>
	<DOC>NCT01395381</DOC>
	<brief_summary>The benefit of anti-worm therapy as part of the case management of severe acute malnutrition (SAM) in the outpatient setting has not previously been studied. This study will compare recovery rates of children with SAM treated in the community with locally-produced ready-to-use therapeutic food (RUTF) with and without prescribed albendazole as part of their case management.</brief_summary>
	<brief_title>Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition</brief_title>
	<detailed_description />
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Severe Acute Malnutrition</mesh_term>
	<mesh_term>Kwashiorkor</mesh_term>
	<mesh_term>Protein-Energy Malnutrition</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<criteria>1259 months old Kwashiorkor and/or Marasmus Qualified for homebased therapeutic feeding with RUTF Obvious congenital or other malformation that makes child a poor candidate for feeding with RUTF Unable to consume testdose of RUTF in clinic Parent refusal to participate and return for followup</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>